Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Guilford (GLFD)

Guilford Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GLFD
DateTimeSourceHeadlineSymbolCompany
29/09/200523:27PR Newswire (US)Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA MergerNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/09/200512:00Business WireMGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting PeriodNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/200515:11PR Newswire (US)Guilford Pharmaceuticals Reports 2005 Second Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/08/200513:45PR Newswire (US)Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
02/08/200519:33PR Newswire (US)Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
24/05/200520:44PR Newswire (US)Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
18/05/200520:00PR Newswire (US)Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCONASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/05/200520:39PR Newswire (US)Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant GliomaNASDAQ:GLFDGuilford Pharmaceuticals (MM)
11/05/200516:01PR Newswire (US)AGGRASTAT(R) Injection Strategy Trial Data Published in JAMANASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/05/200514:42PR Newswire (US)Guilford Pharmaceuticals Reports 2005 First Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
09/05/200513:45PR Newswire (US)Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
02/05/200514:00PR Newswire (US)Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
21/04/200519:07PR Newswire (US)Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development ProgramNASDAQ:GLFDGuilford Pharmaceuticals (MM)
06/04/200513:45PR Newswire (US)Guilford Pharmaceuticals to Host Webcast Outlining New Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/04/200518:31PR Newswire (US)Guilford Pharmaceuticals to Host Webcast Outlining New Corporate StrategyNASDAQ:GLFDGuilford Pharmaceuticals (MM)
24/03/200517:04PR Newswire (US)Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary EndpointNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/03/200516:03PR Newswire (US)Guilford Pharmaceuticals: AGGRASTAT(R) Injection Clinical Data Presented at American College of Cardiology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/03/200520:55PR Newswire (US)Guilford Pharmaceuticals Reports 2004 Year-End Financial ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
01/03/200512:45PR Newswire (US)Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
10/02/200516:42PR Newswire (US)Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005NASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/12/200422:30PR Newswire (US)Guilford Pharmaceuticals Completes Sale and Leaseback and Receives $19.4 Million in Net ProceedsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
02/12/200413:45PR Newswire (US)Guilford Pharmaceuticals to Acquire ProQuest Pharmaceuticals; Guilford to Obtain Exclusive Worldwide Ownership of AQUAVAN(R) ProNASDAQ:GLFDGuilford Pharmaceuticals (MM)
22/11/200414:03PR Newswire (US)Guilford Pharmaceuticals Presents New GLIADEL(R) Wafer Data at the Society for Neuro-Oncology Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/11/200422:30PR Newswire (US)Guilford Pharmaceuticals Announces Equity Compensation Arrangement With Dean J. Mitchell Pursuant to NASDAQ RulesNASDAQ:GLFDGuilford Pharmaceuticals (MM)
17/11/200413:01PR Newswire (US)Dean J. Mitchell Appointed President and Chief Executive Officer of Guilford PharmaceuticalsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
12/11/200415:58PR Newswire (US)AGGRASTAT(R) Strategy Trial Data Presented At American Heart Association Annual MeetingNASDAQ:GLFDGuilford Pharmaceuticals (MM)
08/11/200417:11PR Newswire (US)Guilford Pharmaceuticals Reports 2004 Third Quarter ResultsNASDAQ:GLFDGuilford Pharmaceuticals (MM)
05/11/200413:30PR Newswire (US)Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004NASDAQ:GLFDGuilford Pharmaceuticals (MM)
27/09/200415:33PR Newswire (US)Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends UntilNASDAQ:GLFDGuilford Pharmaceuticals (MM)
22/09/200415:03PR Newswire (US)Guilford to Present at UBS Global Life Sciences ConferenceNASDAQ:GLFDGuilford Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:GLFD